<http://www.wikidata.org/entity/Q92805726>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection"@en .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P577>	<http://www.wikidata.org/entity/statement/Q92805726-CF6CD3EF-6F42-438D-935C-5C9378D359D2> .
<http://www.wikidata.org/entity/Q92805726>	<http://schema.org/description>	"b\u00E0i b\u00E1o khoa h\u1ECDc"@vi .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P1433>	<http://www.wikidata.org/entity/Q15716711> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q40206104> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P1433>	<http://www.wikidata.org/entity/statement/Q92805726-B905320B-2BC1-4A41-8BB2-7330C2D20693> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q92805726-33BE6962-555B-4A24-850D-8AA5B4C1CE59> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P478>	"65" .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P577>	"2019-08-22T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q92805726-BA6D11EB-8175-423E-9CF9-A3028045A46F> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P304>	"632-638" .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct-normalized/P698>	<http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31440997> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P304>	<http://www.wikidata.org/entity/statement/Q92805726-B045461F-9C56-4934-A14C-994D85DF2FF8> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.w3.org/2000/01/rdf-schema#label>	"Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection"@nl .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P1476>	<http://www.wikidata.org/entity/statement/Q92805726-1E627E81-13EA-4EAD-A450-BC19E89C2056> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P31>	<http://www.wikidata.org/entity/Q13442814> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P478>	<http://www.wikidata.org/entity/statement/Q92805726-2D948B62-1F95-4B8C-AAF7-F009FF35017A> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P2093>	"Simon J Hong" .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P356>	"10.1007/S10620-019-05804-2" .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P2093>	"Lawrence J Brandt" .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P433>	<http://www.wikidata.org/entity/statement/Q92805726-3F2EA071-5FBE-4C26-9ACC-41313D70F634> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.w3.org/2000/01/rdf-schema#label>	"Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection"@en .
<http://www.wikidata.org/entity/Q92805726>	<http://schema.org/description>	"im August 2019 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P433>	"2" .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P698>	<http://www.wikidata.org/entity/statement/Q92805726-F27EF218-DE62-426E-A5A2-BDC84D695D46> .
<http://www.wikidata.org/entity/Q92805726>	<http://schema.org/description>	"scientific article published on 22 August 2019"@en .
<http://www.wikidata.org/entity/Q92805726>	<http://schema.org/name>	"Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection"@nl .
<http://www.wikidata.org/entity/Q92805726>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Item> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P698>	"31440997" .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct/P1476>	"Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection"@en .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P31>	<http://www.wikidata.org/entity/statement/Q92805726-7C39C9A0-1BC6-4F9C-91B5-D3B8DBDDDBBF> .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q92805726-0F1F7E87-4BF8-4457-9AC6-372F50B370E0> .
<http://www.wikidata.org/entity/Q92805726>	<http://schema.org/description>	"art\u00EDculu cient\u00EDficu espubliz\u00E1u n'agostu de 2019"@ast .
<http://www.wikidata.org/entity/Q92805726>	<http://schema.org/name>	"Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection"@en .
<http://www.wikidata.org/entity/Q92805726>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection"@nl .
<http://www.wikidata.org/entity/Q92805726>	<http://schema.org/description>	"\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 22 \u0441\u0435\u0440\u043F\u043D\u044F 2019"@uk .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/P356>	<http://www.wikidata.org/entity/statement/Q92805726-1B387469-5FC6-40BC-A2AB-DC848F387E81> .
<http://www.wikidata.org/entity/Q92805726>	<http://schema.org/description>	"wetenschappelijk artikel"@nl .
<http://www.wikidata.org/entity/Q92805726>	<http://www.wikidata.org/prop/direct-normalized/P356>	<http://dx.doi.org/10.1007/S10620-019-05804-2> .